Neoadjuvant modified FOLFIRINOX plus nivolumab in borderline-resectable pancreatic ductal adenocarcinoma: a pilot phase 1 trial
新辅助改良FOLFIRINOX方案联合纳武利尤单抗治疗临界可切除胰腺导管腺癌:一项I期试点试验
期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-026-68976-2
Wainberg, Zev A; Link, Jason M; Premji, Alykhan; Zheng, Serena; Srienc, Michael; Hammons, McKensie; Kim, Shineui E; Li, Luyi; Liu, Zeyu; Tsvetkova, Olga; Abt, Evan R; Rosen, Lee; Kim, Stephen; King, Jonathan; Hines, O Joe; Girgis, Mark; Sadeghi, Saeed; Olevsky, Olga; Wong, Deborah; Yonemoto, Lisa; Siney, Ann Marie; Kelly, Kim; Kivork, Christine; Tseng, Chi-Hong; Radu, Caius G; Dawson, David W; Donahue, Timothy R